NCT01992601View on ClinicalTrials.gov

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions

Healthy Volunteer

Interventions

DRUG

Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg)

"For co-administration, Crestor 1 tablet and Micardis 1 tablet a day for 6 days in each period.~For separate administration, Crestor 1 tablet a day for 6 days and Micardis 1 tablet a day for 6 days in each period."

Trial Locations (1)

120-752

Severance Hospital, Yonsei University, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT01992601 - A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer | Biotech Hunter | Biotech Hunter